| Tretinoin | Approved Investigational Nutraceutical | BORA | 79866 |
downregulated | Tretinoin results in decreased expression of BORA mRNA | 13q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | BORCS7 | 119032 |
upregulated | Tretinoin results in increased expression of BORCS7 mRNA | 10q24.32 | |
| Tretinoin | Approved Investigational Nutraceutical | BPI | 671 |
upregulated | Tretinoin results in increased expression of BPI mRNA | 20q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | BPTF | 2186 |
downregulated | Tretinoin results in decreased expression of BPTF mRNA | 17q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BRAF | 673 |
downregulated | Tretinoin results in decreased expression of BRAF mRNA | 7q34 | |
| Tretinoin | Approved Investigational Nutraceutical | BRCA1 | 672 |
downregulated | Tretinoin results in decreased expression of BRCA1 mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | BRCA1 | 672 |
upregulated | Tretinoin results in increased expression of BRCA1 mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | BRCA2 | 675 |
downregulated | Tretinoin results in decreased expression of BRCA2 mRNA | 13q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BRD3 | 8019 |
downregulated | Tretinoin results in decreased expression of BRD3 mRNA | 9q34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BRINP1 | 1620 |
upregulated | Tretinoin results in increased expression of BRINP1 mRNA | 9q33.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BRSK2 | 9024 |
downregulated | Tretinoin results in decreased expression of BRSK2 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | BRWD1 | 54014 |
upregulated | Tretinoin results in increased expression of BRWD1 mRNA | 21q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BST2 | 684 |
downregulated | Tretinoin results in decreased expression of BST2 mRNA | 19p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | BST2 | 684 |
upregulated | Tretinoin results in increased expression of BST2 mRNA | 19p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | BTBD11 | 121551 |
upregulated | Tretinoin results in increased expression of BTBD11 mRNA | 12q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | BTC | 685 |
downregulated | Tretinoin results in decreased expression of BTC mRNA | 4q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | BTG1 | 694 |
upregulated | Tretinoin results in increased expression of BTG1 mRNA | 12q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | BTG2 | 7832 |
upregulated | Tretinoin results in increased expression of BTG2 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BTN2A2 | 10385 |
upregulated | Tretinoin results in increased expression of BTN2A2 mRNA | 6p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BTN3A1 | 11119 |
upregulated | Tretinoin results in increased expression of BTN3A1 mRNA | 6p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BTN3A2 | 11118 |
upregulated | Tretinoin results in increased expression of BTN3A2 mRNA | 6p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BTN3A3 | 10384 |
upregulated | Tretinoin results in increased expression of BTN3A3 mRNA | 6p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BTNL2 | 56244 |
downregulated | Tretinoin results in decreased expression of BTNL2 mRNA | 6p21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | BUB1 | 699 |
downregulated | Tretinoin results in decreased expression of BUB1 mRNA | 2q13 | |
| Tretinoin | Approved Investigational Nutraceutical | BVES | 11149 |
upregulated | Tretinoin results in increased expression of BVES mRNA | 6q21 | |